ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor Tovora…

2024 ASCO® Annual Meeting Insights Hub

D. Ziegler

Effective Strategies for Managing IDH-Mutant Gliomas

Matteo Simonelli

LITT for Deep-Seated Perivascular Brain Tumors: Evaluating the Risk …

Hassan Fadel

BRAF in the MAPK Pathway for Pediatric Low-Grade Glioma: Current Tes…

Avani Mangoli

Biomarkers in Diffuse Midline Glioma

University of Colorado Department of Medicine

A. Green

Pediatric Low Grade Glioma: Radiation in the Targeted Therapy Era

Rene McNall-Knapp

Penn Medicine Updates on Brain Tumors

Penn Medicine Abramson Cancer Center

S. Bagley

Overview and Updates in Brain Tumors

Henry Friedman

Primary Brain Tumors: Targeting Metabolism in Glioma

UNC Lineberger Comprehensive Cancer Center

D. Higgins

MIPS in Tumor Applications: Deep Brain Lesions a Review of Current S…

Subcortical Surgery Group

K. Chaichana

Should We Treat Seizures Associated With Tumors Differently?

Edward Avila

Anterior Petrosectomy for Petroclival Meningioma: Preliminary Experi…

Weill Cornell Medicine Courses and Meetings

C. Hong

Fluorescence-Guided Surgery for Non-Enhancing Tumors

Mount Sinai Fluorescence-Guided Surgery Symposium

N. Sanai

New Advances in Minimally Invasive Brain Surgery: What You Need to K…

2020 South Florida Neuroscience Symposium

R. Komotar

Neurosurgical Targets for Chronic Pain

UCLA Health

J. Langevin

Why 5-ALA Fluorescence-Guided Surgery (FGS) for Brain Tumors?

Mount Sinai Fluorescence-Guided Surgery Symposium

C. Hadjipanayis

Electrocorticography and Functional Cortical Mapping

Houston Methodist

A. Verma

Neurosurgeons and Clinical Trials in Glioblastoma

Weill Cornell Medicine Courses and Meetings

R. Ramakrishna

Exercise: Connectomics for Target Picking for Interventional Neurore…

Subcortical Surgery Group

M. Sughrue

Treatment Options for Recurrent High-Grade Gliomas

Mount Sinai Fluorescence-Guided Surgery Symposium

M. Berger